تجاوز إلى المحتوى الرئيسي
من
المنتج التاريخ معلومات السلامة المرفقات
Levofloxacin Sandoz (Levofloxacin) 2020-09-13

Systemic fluoroquinolones: risk of heart valve regurgitation

Curacne (Isotretinoin) 2020-08-19

Isotretinoin - update on teratogenicity and neuropsychiatric disorders

Verorab (Rabies Vaccine, Inactivated) 2020-07-19

Updated information on the reconstitution and administration of rabies vaccine, inactivated (VERORAB)

Megamox (Amoxicillin / Clavulanic acid) 2020-05-06

Megamox® 625mg tablets is associated with a typographic error in the units for the weight of the product stated on the aluminum foil.

Esbriet® (Pirfenidone) 2019-12-08

Important Safety Update on ESBRIET® (pirfenidone) and Drug-Induced Liver Injury (DILI)

Advaquin ( levofloxacin) 2019-08-13

Advaquin ( levofloxacin): Risk of aortic aneurysm and dissection.

Apixaban, Edoxaban, Dabigatran and Rivaroxaban 2019-06-12

Direct Healthcare Professional Communication (DHPC) for the Direct Oral Anticoagulants (DOACs) Apixaban, Edoxaban, Dabigatran and Rivaroxaban.

blinatumomab 2019-05-07

Blincyto (pembrolizumab): Risk of Medication Errors and Benzyl alcohol toxicity​.

Jectin-12® (Cyanocobalamin) 2019-05-06

Cyanocobalamin and the risk of medication error.

Genvoya ® (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide) 2019-04-29

Increased risk of treatment failure and increased risk of mother-to-child transmission of HIV infection due to lower exposure of elvitegravir and cobicistat during the second and third trimesters of pregnancy.

عرض 1 - 10 من 21